DSS Names Grady Interim CEO

Dow Jones08-27

By Connor Hart

DSS has named Jason Grady as its interim chief executive officer.

Grady assumed the role on Friday succeeding Frank Heuszel, who left to transition to a leadership role within one of its former subsidiaries, the New York paper products company said on Monday.

Grady has held various positions at DSS including chief executive officer and director of DSS Biohealth.

Heuszel will transition to a leadership role at Impact Biomedical, which works to discover, confirm and patent science and technologies in human healthcare and wellness.

Write to Connor Hart at connor.hart@wsj.com

 

(END) Dow Jones Newswires

August 26, 2024 16:24 ET (20:24 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment